The focus of this renewal application continues to be on the molecular basis of hematopoiesis. Specifically, we are interested in the role of proto-oncogenes and immediate early response genes m leukemic cell differentiation and cell cycle progression. During the previous granting period, we established that several such genes (c-myc, c-myb, and jun family members) are intimately involved in these processes. In the continuation of this work, we will study the contributions that protein:protein and protein:DNA interactions make to these events. In keeping with our long-standing interest in the c-myc oncoprotein, we will begin to explore, both in vitro as well as in transgenic animals, the molecular and biological consequences of its interaction with the recently described max proteins. Point mutations will be used to define those amino acid residues critical to the overall function and specificity of the c-myc DNA binding domain Finally, we will utilize bacterially expressed """"""""Id"""""""" protein, a known negative regulator of """"""""helix-loop-helix"""""""" proteins, as an affinity reagent to purify and clone positive regulators of erythroleukemic differentiation. The above studies will thus expand and refine our current notions of the roles of oncoproteins in erythroleukemic differentiation and may uncover novel pathways leading to these events.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL033741-10
Application #
3345915
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1984-07-01
Project End
1997-08-31
Budget Start
1993-09-16
Budget End
1994-08-31
Support Year
10
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Children's Hosp Pittsburgh/Upmc Health Sys
Department
Type
DUNS #
044304145
City
Pittsburgh
State
PA
Country
United States
Zip Code
15224
Rothermund, Krisiti; Rogulski, Kenneth; Fernandes, Elaine et al. (2005) C-Myc-independent restoration of multiple phenotypes by two C-Myc target genes with overlapping functions. Cancer Res 65:2097-107
Rogulski, Kenneth; Li, Youjun; Rothermund, Kristi et al. (2005) Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway. Oncogene 24:7524-41
Prochownik, E V (2005) Functional and physical communication between oncoproteins and tumor suppressors. Cell Mol Life Sci 62:2438-59
Egler, Rachel A; Fernandes, Elaine; Rothermund, Kristi et al. (2005) Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene 24:8038-50
Yin, Xiaoying; Giap, Christine; Lazo, John S et al. (2003) Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene 22:6151-9
Mu, Zhao Mei; Yin, Xiao Ying; Prochownik, Edward V (2002) Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. J Biol Chem 277:43175-84
Yin, Xiaoying; Grove, Linnette; Rogulski, Kenneth et al. (2002) Myc target in myeloid cells-1, a novel c-Myc target, recapitulates multiple c-Myc phenotypes. J Biol Chem 277:19998-20010
Yin , X; Landay, M F; Han, W et al. (2001) Dynamic in vivo interactions among Myc network members. Oncogene 20:4650-64
Yin, X Y; Grove, L E; Prochownik, E V (2001) Mmip-2/Rnf-17 enhances c-Myc function and regulates some target genes in common with glucocorticoid hormones. Oncogene 20:2908-17
Yin, X Y; Grove, L; Datta, N S et al. (2001) Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression. Cancer Res 61:6487-93

Showing the most recent 10 out of 38 publications